Mechanisms of fluoroquinolone resistance in Escherichia coli Isolates from food-producing animals

Applied and Environmental Microbiology

Volumn 77, Issue 20, 2011, Pages 7113-7120

  Karczmarczyk, Maria ^a   Martins, Marta ^a,b   Quinn, Teresa ^a   Leonard, Nola ^a   Fanning, Séamus ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; CIPROFLOXACIN; DNA SEQUENCING; E. COLI; EFFLUX PUMPS; ETHIDIUM BROMIDE; FLUOROQUINOLONES; FOOD-PRODUCING ANIMALS; GENES CODING; IRELAND; NALIDIXIC ACID; PUMP COMPONENTS; Q-RT-PCR; QUANTITATIVE REAL TIME PCR; QUINOLONES; SEMI-AUTOMATED; TARGET GENES; UP-REGULATION; WILD TYPES;

AMINO ACIDS; ANIMALS; ANTIBIOTICS; BROMINE COMPOUNDS; ESCHERICHIA COLI; GENE ENCODING; HOSPITALS; POLYMERASE CHAIN REACTION; PROTEINS;

GENE EXPRESSION;

ANTIINFECTIVE AGENT; BACTERIAL DNA; CARRIER PROTEIN; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); ESCHERICHIA COLI PROTEIN; NALIDIXIC ACID; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BIOACCUMULATION; BIOASSAY; BIOLOGICAL UPTAKE; BROMIDE; COLIFORM BACTERIUM; FOOD PRODUCTION; GENE EXPRESSION; MUTATION; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS;

ANIMAL; ANIMAL DISEASE; ANIMAL HUSBANDRY; ARTICLE; CHEMISTRY; DNA SEQUENCE; DRUG EFFECT; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE EXPRESSION PROFILING; GENETICS; IRELAND; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ANIMAL HUSBANDRY; ANIMALS; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DNA GYRASE; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FLUOROQUINOLONES; GENE EXPRESSION PROFILING; IRELAND; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; SEQUENCE ANALYSIS, DNA;

COUNTY DUBLIN; IRELAND; LEINSTER;

EID: 82955206474     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00600-11     Document Type: Article

References (48)

1. Ahmed, A. M., S. Miyoshi, S. Shinoda, and T. Shimamoto. 2005. Molecular characterisation of a multidrug-resistant strain of enteroinvasive Escherichia coli O164 isolated in Japan. J. Med. Microbiol. 54:273-278.
2. Alekshun, M. N., and S. B. Levy. 1997. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob. Agents Chemother. 41:2067-2075.
3. Alekshun, M. N., S. B. Levy, T. R. Mealy, B. A. Seaton, and J. F. Head. 2001. The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 Å resolution. Nat. Struct. Biol. 8:710-714.
4. Amaral, L., S. Fanning, and J. M. Pagès. 2011. Efflux pumps of gramnegative bacteria: genetic responses to stress and the modulation of their activity by pH, inhibitors, and phenothiazines. Adv. Enzymol. Relat. Areas Mol. Biol. 77:61-108.
5. Barnard, F. M., and A. Maxwell. 2001. Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87). Antimicrob. Agents Chemother. 45:1994-2000.
6. Chander, M., and B. Demple. 2004. Functional analysis of SoxR residues affecting transduction of oxidative stress signals into gene expression. J. Biol. Chem. 279:41603-41610.
7. Chou, J. H., J. T. Greenberg, and B. Demple. 1993. Posttranscriptional repression of Escherichia coli OmpF protein in response to redox stress: positive control of the micF antisense RNA by the soxRS locus. J. Bacteriol. 175:1026-1031.
8. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, 3rd ed. CLSI document M31-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Cohen, S. P., L. M. McMurry, and S. B. Levy. 1988. marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J. Bacteriol. 170:5416-5422.
10. Cohen, S. P., L. M. McMurry, D. C. Hooper, J. S. Wolfson, and S. B. Levy. 1989. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob. Agents Chemother. 33:1318-1325.
11. Everett, M. J., Y. F. Jin, V. Ricci, and L. J. Piddock. 1996. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Chemother. 40:2380-2386.
12. Fendukly, F., I. Karlsson, H. S. Hanson, G. Kronvall, and K. Dornbusch. 2003. Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin. APMIS 111:857-866.
13. Gagliotti, C., R. Buttazzi, S. Sforza, M. L. Moro, and Emilia-Romagna Antibiotic Resistance Study Group. 2008. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli. J. Infect. 57:179-184.
14. Heisig, P. 1996. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40:879-885.
15. Hopkins, K. L., R. H. Davies, and E. J. Threlfall. 2005. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int. J. Antimicrob. Agents 25:358-373.
16. Karczmarczyk, M., et al. 2010. Characterization of antimicrobial resistance in Salmonella enterica food and animal isolates from Colombia: identification of a qnrB19-mediated quinolone resistance marker in two novel serovars. FEMS Microbiol. Lett. 313:10-19.
17. Karczmarczyk, M., Y. Abbott, C. Walsh, N. Leonard, and S. Fanning. 2011. Characterization of multidrug-resistant Escherichia coli isolates from animals presenting at a university veterinary hospital. Appl. Environ. Microbiol. 77:7104-7112.
18. Kern, W. V., M. Oethinger, A. S. Jellen-Ritter, and S. B. Levy. 2000. Nontarget gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 44:814-820.
19. Kishii, R., and M. Takei. 2009. Relationship between the expression of ompF and quinolone resistance in Escherichia coli. J. Infect. Chemother. 15:361-366.
20. Komp Lindgren, P., L. L. Marcusson, D. Sandvang, N. Frimodt-Møller, and D. Hughes. 2005. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob. Agents Chemother. 49:2343-2351.
21. Koutsolioutsou, A., S. Pena-Llopis, and B. Demple. 2005. Constitutive soxR mutations contribute to multiple-antibiotic resistance in clinical Escherichia coli isolates. Antimicrob. Agents Chemother. 49:2746-2752.
22. Kwon, H. J., M. H. Bennik, B. Demple, and T. Ellenberger. 2000. Crystal structure of the Escherichia coli Rob transcription factor in complex with DNA. Nat. Struct. Biol. 7:424-430.
23. Linde, H. J., et al. 2000. In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR. Antimicrob. Agents Chemother. 44:1865-1868.
24. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
25. Mazzariol, A., Y. Tokue, T. M. Kanegawa, G. Cornaglia, and H. Nakaido. 2000. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob. Agents Chemother. 44:3441-3443.
26. Moon, D. C., et al. 2010. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates. Int. J. Antimicrob. Agents 35:76-79.
27. Morgan-Linnell, S. K., L. Becnel Boyd, D. Steffen, and L. Zechiedrich. 2009. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates. Antimicrob. Agents Chemother. 53:235-241.
28. Mortimer, P. G., and L. J. Piddock. 1991. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J. Antimicrob. Chemother. 28:639-653.
29. Oethinger, M., W. V. Kern, A. S. Jellen-Ritter, L. M. McMurry, and S. B. Levy. 2000. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob. Agents Chemother. 44:10-13.
30. Oram, M., and L. M. Fisher. 1991. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob. Agents Chemother. 35:387-389.
31. Ozeki, S., et al. 1997. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections. J. Clin. Microbiol. 35:2315-2319.
32. Rosenberg, E. Y., D. Bertenthal, M. L. Nilles, K. P. Bertrand, and H. Nikaido. 2003. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol. Microbiol. 48:1609-1619.
33. Sáenz, Y., et al. 2004. Effect of the efflux pump inhibitor Phe-Arg-betanaphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J. Antimicrob. Chemother. 53:544-545.
34. Sorlozano, A., J. Gutierrez, A. Jimenez, J. de Dios Luna, and J. L. Martínez. 2007. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-β-lactamase-producing Escherichia coli isolates. J. Clin. Microbiol. 45:2740-2742.
35. Strahilevitz, J., G. A. Jacoby, D. C. Hooper, and A. Robicsek. 2009. Plasmidmediated quinolone resistance: a multifaceted threat. Clin. Microbiol. Rev. 22:664-689.
36. Tavío, M. M., et al. 1999. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. J. Antimicrob. Chemother. 44:735-742.
37. Tsai, F. T., et al. 1997. The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin. Proteins 28:41-52.
38. Vila, J., J. Ruiz, P. Goni, and M. T. De Anta. 1996. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40:491-493.
39. Viveiros, M., et al. 2008. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated EB method. Int. J. Antimicrob. Agents. 31:458-462.
40. Viveiros, M., et al. 2007. Antibiotic stress, genetic response and altered permeability of E. coli. PLoS One 2:e365.
41. Wang, H., J. L. Dzink-Fox, M. Chen, and S. B. Levy. 2001. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob. Agents Chemother. 45: 1515-1521.
42. Watanabe, S., A. Kita, K. Kobayashi, and K. Miki. 2008. Crystal structure of the [2Fe-2S] oxidative-stress sensor SoxR bound to DNA. Proc. Natl. Acad. Sci. U. S. A. 105:4121-4126.
43. Webber, M. A., and L. J. Piddock. 2001. Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. Antimicrob. Agents Chemother. 45:1550-1552.
44. Webber, M. A., A. Talukder, and L. J. Piddock. 2005. Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates. Antimicrob. Agents Chemother. 49:4390-4392.
45. Yang, S., S. R. Clayton, and E. L. Zechiedrich. 2003. Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J. Antimicrob. Chemother. 51:545-556.
46. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
47. Yoshida, H., M. Bogaki, M. Nakamura, L. M. Yamanaka, and S. Nakamura. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35:1647-1650.
48. Zgurskaya, I. H., and H. Nikaido. 1999. Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 96:7190-7195.